FDA Inspection
Centaur Pharmaceuticals Private Ltd.Centaur Pharmaceuticals Private Ltd. – FDA Inspection, Feb 8, 2023
Record Details
This FDA Inspection record concerns Centaur Pharmaceuticals Private Ltd., with an inspection on February 8, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 2e11e9b3-3ae0-4157-8a97-9c1f32c046ba
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1198364
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
- Enforcement
- Warning Letter
Other FDA inspections of Centaur Pharmaceuticals Private Ltd.
5| Date | Classification | Office | Project area |
|---|---|---|---|
| August 24, 2026 | Not classified | Office of Inspections and Investigations | Drug Quality Assurance |
| May 13, 2019 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 14, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 27, 2014 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 19, 2011 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Centaur Pharmaceuticals Private Ltd.
- FDA Inspection 1333532 - 2026-08-24
- FDA Inspection 1092125 - 2019-05-13
- FDA Inspection 1002848 - 2016-11-14
- FDA Inspection 871580 - 2014-03-27
- FDA Inspection 740704 - 2011-08-19
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.